iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides ...
Q3 2026
May 12, 2026
Q2 2026
Feb 10, 2026
Q1 2026
Nov 12, 2025
FY 2025
Sep 5, 2025
Q4 2025